The advisers considered CDC data that showed protection from two doses starts to wane over time, and that boosters in older age groups improved efficacy against severe COVID.
Read this story at Global News
The advisers considered CDC data that showed protection from two doses starts to wane over time, and that boosters in older age groups improved efficacy against severe COVID.
Read this story at Global News